RE:RE:Re:: XTR Excellent post ICT.
I'll give Bakema credit, he sticks to the thought that Lubow and "his" backers are Corp Raiders who only want to steal the IP. Lol. Lubow and Hellman (the others as well) go way back and it was Lubow who helped the stakeholders of Hellman's public company recover $80m in bankruptcy when the creditors who put it into BK were offering shareholders $2.5m how do I know that?? I was one of them. Then, like now, he was a champion for stakeholders and went out of his way to help.
Does anyone actually know how much stock Lubow owns? If you read the filings he and the four other execs who simultaneously resigned were owed about $500k that I am told they were all going to forgive once the 2019 restructuring was approved that was on top of the time (18 months) that they all put time without compensation into "fixing" this mess. All of their respective stock options which they all deserved went up in smoke.
I've seen the 1st presentation shown to investors at a roadshow in FL that Bakema stated "I've got $8m personally invested and Global has invested $24m to date ( those both turned out to be factual lies) but the thing that stood out was he emphatically stated "we need $5m and we are 6 months from our FDA submission" that was late in 2017. How do I know you ask?? I was there.
This failed for obvious reasons, foolish greed, incompetent leadership at Global and lack of transparency at Global not because of anything CVR Medical did, that company did its part. Lubow did his job. Why don't you ask the 7 others who resigned who brought them to CVR Med, they were all (except Hack) relationships forged by Lubow over 20-25 years and to boot helped raise $28m which I'm told about $8m came from close friends and family relationships of his. If you look at their respective bios, they "work" together on other very successful ventures none of which were Corp raided entities
what's next?? Who the heck knows, the odds are stacked against us, two attempts to fix making this investable failed because PK wanted things that made it uninvestable hence why for the past two plus years the only investment into Medical was used to keep it compliant with the Exchange which were loans by directors and the tech has not been advanced one iota.
I don't think it's a "stalemate", I personally think it's "Check" and if PK, Blunden, Lynch and Global don't make the right decision I'm afraid it will be "CheckMate"